BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22817126)

  • 1. Role of apheresis and dialysis in pediatric living donor liver transplantation: a single center retrospective study.
    Sanada Y; Mizuta K; Urahashi T; Ihara Y; Wakiya T; Okada N; Yamada N; Koinuma T; Koyama K; Tanaka S; Misawa K; Wada M; Nunomiya S; Yasuda Y; Kawarasaki H
    Ther Apher Dial; 2012 Aug; 16(4):368-75. PubMed ID: 22817126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of anti-allogeneic antibody elimination by apheresis in living donor liver transplantation.
    Kawagishi N; Takeda I; Miyagi S; Satoh K; Akamatsu Y; Sekiguchi S; Fujimori K; Sato T; Satomi S
    Ther Apher Dial; 2007 Oct; 11(5):319-24. PubMed ID: 17845390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of ABO-incompatible living-donor liver transplantation: a single-center experience.
    Kawagishi N; Takeda I; Miyagi S; Satoh K; Akamatsu Y; Sekiguchi S; Satomi S
    J Hepatobiliary Pancreat Surg; 2009; 16(4):468-72. PubMed ID: 19333538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation.
    Kozaki K; Egawa H; Kasahara M; Oike F; Yoshizawa A; Fukatsu A; Tanaka K
    Ther Apher Dial; 2005 Aug; 9(4):285-91. PubMed ID: 16076368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABO-incompatible living donor liver transplantation: new insights into clinical relevance.
    Kawagishi N; Satomi S
    Transplantation; 2008 Jun; 85(11):1523-5. PubMed ID: 18551048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of apheresis therapy for ABO incompatible living donor liver transplantation: the Kyoto University experience.
    Kozaki K; Egawa H; Ueda M; Oike F; Yoshizawa A; Fukatsu A; Takada Y
    Ther Apher Dial; 2006 Oct; 10(5):441-8. PubMed ID: 17096700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Present status of ABO-incompatible living donor liver transplantation in Japan.
    Egawa H; Teramukai S; Haga H; Tanabe M; Fukushima M; Shimazu M
    Hepatology; 2008 Jan; 47(1):143-52. PubMed ID: 17929298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of plasmapheresis therapy for perioperative management in ABO-incompatible adult living donor liver transplantation.
    Ashizawa T; Matsuno N; Yokoyama T; Kihara Y; Kuzuoka K; Taira S; Konno O; Jyojima Y; Akashi I; Nakamura Y; Hama K; Iwamoto H; Iwahori T; Nagao T; Kasahara M; Tanaka K
    Transplant Proc; 2006 Dec; 38(10):3629-32. PubMed ID: 17175351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of rituximab in ABO-incompatible pediatric living donor liver transplantation: the experience of a single center.
    Okada N; Sanada Y; Hirata Y; Yamada N; Wakiya T; Ihara Y; Urahashi T; Miki A; Kaneda Y; Sasanuma H; Fujiwara T; Sakuma Y; Shimizu A; Hyodo M; Yasuda Y; Mizuta K
    Pediatr Transplant; 2015 May; 19(3):279-86. PubMed ID: 25689881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult ABO-incompatible liver transplantation, using A and B donors.
    Skogsberg U; Breimer ME; Friman S; Mjörnstedt L; Mölne J; Olausson M; Rydberg L; Svalander CT; Bäckman L
    Xenotransplantation; 2006 Mar; 13(2):154-9. PubMed ID: 16623811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of tandem hemodialysis and immunoadsorption to desensitize kidney transplant candidates.
    Rostaing L; Maggioni S; Hecht C; Hermelin M; Faudel E; Kamar N; Sallusto F; Doumerc N; Allal A
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():165-9. PubMed ID: 25894148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation.
    Egawa H; Oike F; Buhler L; Shapiro AM; Minamiguchi S; Haga H; Uryuhara K; Kiuchi T; Kaihara S; Tanaka K
    Transplantation; 2004 Feb; 77(3):403-11. PubMed ID: 14966415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apheresis therapy for living-donor liver transplantation: experience for apheresis use for living-donor liver transplantation at Kyoto University.
    Kozaki K; Kasahara M; Oike F; Ogawa K; Fujimoto Y; Ogura Y; Ueda M; Kaihara S; Fukatsu A; Tanaka K
    Ther Apher; 2002 Dec; 6(6):478-83. PubMed ID: 12460415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First two ABO-incompatible living renal transplantations using splenectomy, rituximab, plasmapheresis and IVIG as a preconditioning regimen: a single center experience in the Balkans.
    Ivanovski N; Popov Z; Masin-Spasovska J; Dimcevska AH; Kolevski P
    Xenotransplantation; 2006 Mar; 13(2):123-5. PubMed ID: 16623805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual living donor liver transplantation with ABO-incompatible and ABO-compatible grafts to overcome small-for-size graft and ABO blood group barrier.
    Song GW; Lee SG; Hwang S; Kim KH; Ahn CS; Moon DB; Ha TY; Kwon SW; Ko GY; Kim KW
    Liver Transpl; 2010 Apr; 16(4):491-8. PubMed ID: 20222051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paired donor interchange to avoid ABO-incompatible living donor liver transplantation.
    Chan SC; Lo CM; Yong BH; Tsui WJ; Ng KK; Fan ST
    Liver Transpl; 2010 Apr; 16(4):478-81. PubMed ID: 20373459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantation.
    Haga H; Egawa H; Shirase T; Miyagawa A; Sakurai T; Minamiguchi S; Yamabe H; Manabe T; Tanaka K
    Liver Transpl; 2004 Jan; 10(1):16-27. PubMed ID: 14755773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with a new apheresis filter that specifically depletes ABO blood group antibodies.
    Kumlien G; Ullström L; Losvall A; Persson LG; Tydén G
    Transfusion; 2006 Sep; 46(9):1568-75. PubMed ID: 16965585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ABO incompatible living donor kidney transplantation: a dream come true. Experience of Hospital Clínic of Barcelona].
    Oppenheimer F; Revuelta I; Serra N; Lozano M; Gutiérrez-Dalmau A; Esforzado N; Cofán F; Ricart MJ; Torregrosa JV; Crespo M; Paredes D; Martorell J; Alcáraz A; Campistol JM
    Nefrologia; 2010; 30(1):54-63. PubMed ID: 20038970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABO-incompatible deceased donor liver transplantation in the United States: a national registry analysis.
    Stewart ZA; Locke JE; Montgomery RA; Singer AL; Cameron AM; Segev DL
    Liver Transpl; 2009 Aug; 15(8):883-93. PubMed ID: 19642117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.